ID: ALA3706586

Max Phase: Preclinical

Molecular Formula: C23H34N2O2

Molecular Weight: 370.54

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)(C)NC(=O)[C@H]1CCC2C3CNC4=CC(=O)C=C[C@]4(C)C3CC[C@@]21C

Standard InChI:  InChI=1S/C23H34N2O2/c1-21(2,3)25-20(27)18-7-6-16-15-13-24-19-12-14(26)8-10-23(19,5)17(15)9-11-22(16,18)4/h8,10,12,15-18,24H,6-7,9,11,13H2,1-5H3,(H,25,27)/t15?,16?,17?,18-,22+,23-/m1/s1

Standard InChI Key:  WULOIBNYBPVLMK-UBCBZESQSA-N

Associated Targets(Human)

Steroid 5-alpha-reductase 1 755 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Steroid 5-alpha-reductase 2 937 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 370.54Molecular Weight (Monoisotopic): 370.2620AlogP: 3.59#Rotatable Bonds: 1
Polar Surface Area: 58.20Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.16CX LogP: 2.79CX LogD: 2.79
Aromatic Rings: 0Heavy Atoms: 27QED Weighted: 0.74Np Likeness Score: 1.46

References

1. Frye SV, Haffner CD, Maloney PR, Mook RA, Dorsey GF, Hiner RN, Cribbs CM, Wheeler TN, Ray JA, Andrews RC..  (1994)  6-Azasteroids: structure-activity relationships for inhibition of type 1 and 2 human 5 alpha-reductase and human adrenal 3 beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomerase.,  37  (15): [PMID:8057283] [10.1021/jm00041a014]

Source